If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPublic Policy Regulatory News (PPHC)

Share Price Information for Public Policy (PPHC)

Share Price is delayed by 15 minutes
Get Live Data
605.00    10.00 (1.68%)
Bid:
590.00
Ask:
620.00
Spread: 30.00 (5.085%)
Market Cap: £181.54m
PPHC Live PriceLast checked at - London Stock Exchange

Intraday Public Policy Share Chart

PPHC Launches Concordant Advisory

13 Nov 2023 12:00

RNS Number : 2520T
Public Policy Holding Company, Inc.
13 November 2023
 

 

RNS REACH

13 November 2023

 

Public Policy Holding Company, Inc.

 

("PPHC", the "Group" or the "Company")

 

PPHC Launches Concordant Advisory

 

Supports organic growth and expands PPHC's offering in corporate advisory services

 

Public Policy Holding Company, Inc., the government relations and public affairs group of companies providing a comprehensive range of advisory services, is pleased to announce the launch of Concordant Advisory ("Concordant"), a new Group operating entity that integrates its policy expertise and communications capabilities.

 

Delivering results under a unified plan, team, and pricing structure, Concordant will provide its clients with industry-leading government relations, public affairs, audience insight capabilities and full-service, strategic communications.

 

Based in Chicago, Concordant will be led by Sarah Wills, CEO. Ms Wills is a former Executive Vice President and Chief Corporate Affairs Officer at Cardinal Health, where she presided over communications, government relations, enterprise marketing and brand. Prior to Cardinal Health, Sarah served in leadership roles within government relations, communications and strategy at GE, and led corporate affairs at Tempus, an AI-enabled precision medicine business. Before her corporate career, Sarah spent fifteen years in politics and policy, initially as an Associate for David Axelrod and Associates, then several years as a Legislative Assistant on Capitol Hill, Senior Policy Counsel to the Governor of New Jersey, and Executive Director for New Jobs for New York, a 501(c)(3) launched by then U.S. Senator Hillary Rodham Clinton.

 

Concordant will build multi-disciplinary teams to service client organisations that are investing for long-term growth and resilience, such as AI, progress towards a healthier planet, advancements in precision medicine and the reconfiguration of global supply chains.

 

Stewart Hall, CEO of PPHC, commented:

"Today's launch of Concordant is aligned with PPHC's organic growth strategy and will accelerate our expansion into the growing market for corporate advisory solutions. 

 

"I'm pleased to welcome Sarah to PPHC and look forward to partnering with her to continue to build and integrate PPHC's unique bi-partisan policy expertise, nationwide coverage, in addition to broad public affairs and communications capabilities across our operating companies."

 

Sarah Wills, CEO of Concordant, added:

"Globally, policy and politics shape every major market theme, from technology driven growth opportunities, to the risks generated from shifting geopolitics and monetary policy. In today's uniquely dynamic market, Concordant is set to further empower c-suite leaders and boards with more control over their operating landscapes."

 

Enquiries

Public Policy Holding Company Inc.

Stewart Hall, CEO

Roel Smits, CFO

Thomas Gensemer, Chief Strategy Officer

 

+1 (202) 688 0020

 

Stifel (Nominated Adviser & Broker)

Fred Walsh, Tom Marsh

 

+44 (0) 20 7710 7600

Buchanan Communications (Media Enquiries)

Chris Lane, Toto Berger

+44 (0) 20 7466 5000 pphc@buchanan.uk.com

 

About PPHC

Incorporated in 2014, PPHC is a US-based government relations and public affairs group providing clients with a fully integrated and comprehensive range of services including government and public relations, research and digital advocacy campaigns. Retained by over two-thirds of its 1000+ clients, including corporates, trade associations and non-governmental organisations, the Group is active in all major sectors of the U.S. economy, including healthcare and pharmaceuticals, financial services, energy, technology, telecoms and transportation. PPHC's services support clients to enhance and defend their reputations, advance policy goals, manage regulatory risk, and engage with US federal and state-level policy makers, stakeholders, media and the public.

 

PPHC operates a holding company structure and currently has eight operating entities comprising Crossroads Strategies, Forbes Tate Partners, Seven Letter, O'Neill & Associates, Alpine Group Partners, KP Public Affairs, MultiState Associates and Concordant Advisory. Operating in the strategic communications market, the Group has a strong track record of organic and acquisitive growth, the latter focused on enhancing its capabilities and to establish new verticals, either within new geographies or new related offerings.

 

For more information, see www.pphcompany.com.

 

About Concordant

Launched in November 2023, Concordant is an elite advisory firm designed to serve organizations for whom global public policy represents a crossroads between existential risk and transformational growth. A subsidiary of PPHC, Concordant's mission is to create value by engaging multi-jurisdictional government relations, strategic communications, public affairs and research to propel organizations' long-term strategic plans; all delivered with one plan, one team, one contract and one price. Concordant's counsel reflects the dynamic nature of today's markets, where policy influences the shape of every major global theme, from markets, technology, the repricing of money and shifting geopolitics. Drawn from leaders in Fortune 20 companies, Concordant operates seamlessly in rapidly evolving contexts and features multi-disciplinary teams structured around key market themes.

 

For more information, visit www.concordantadvisory.com.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUOVRROAUAAAA
Date   Source Headline
1st Jul 20261:30 pmRNSAcquisition of Tancredi
15th Jun 202612:05 pmRNSLTIP Awards, TVR and PDMR Dealings
12th Jun 20266:24 pmRNSPDMR Dealings
9th Jun 20266:22 pmRNSVesting of RSUs, Issue of Shares and TVR
29th May 20267:00 amRNS-RPPHC to Join Stifel’s 9th Annual Boston Conference
18th May 20267:00 amRNSFiling of Form 10-Q
13th May 20263:57 pmRNSShare Cancellation and Total Voting Rights
13th May 20267:00 amRNSPPHC Announces Q1 2026 Financial Results
12th May 20264:39 pmRNSResult of AGM
1st May 20267:00 amRNSTalent Acquisition and TVR
28th Apr 202612:00 pmRNSNotice of Q1 Trading Update
20th Apr 20267:00 amRNSNotice of AGM and Posting of Annual Report
10th Apr 20267:00 amRNSIssue of Shares and Total Voting Rights
1st Apr 20267:00 amRNSCompletion of Acquisition, Issue of Shares and TVR
1st Apr 20267:00 amRNSForm 10-K
27th Mar 20267:00 amRNSPPHC Announces FY 2025 Results - Replacement
24th Mar 20267:00 amRNS-RPPHC Added to Russell 2000® and 3000® Indexes
24th Mar 20267:00 amRNSPPHC Announces Full Year 2025 Financial Results
23rd Mar 20267:00 amRNS-RAppointment of Chief Administrative Officer
23rd Mar 20267:00 amRNSShare Cancellation and TVR
23rd Mar 20267:00 amRNSAcquisition of WPI Strategy
9th Mar 20267:00 amRNSIssue of Shares and Total Voting Rights
5th Mar 202612:00 pmRNSNotice of Results
5th Mar 20267:00 amRNSIssue of Shares and Total Voting Rights
2nd Mar 20267:00 amRNSIssue of Shares and Total Voting Rights
11th Feb 20267:30 amRNSNotification of Major Holdings
30th Jan 20263:48 pmRNSPDMR Dealings
29th Jan 20264:00 pmRNSTotal Voting Rights
28th Jan 202612:01 pmRNSBoard Appointments
28th Jan 202612:00 pmRNSPPHC Announces Nasdaq Listing & Pricing of US IPO
22nd Jan 202612:00 pmRNSPPHC Announces Launch of IPO Roadshow
20th Jan 20267:00 amRNSFY2025 Trading Update
12th Jan 20267:00 amRNSProgress re Proposed US IPO
7th Jan 20267:00 amRNSShare Cancellation and TVR
2nd Jan 20267:00 amRNSTalent Acquisition, Share Cancellation and TVR
13th Nov 20257:00 amRNS2025 Q3 Results
29th Oct 20257:00 amRNSVesting of RSUs, Issue of Shares and TVR
22nd Oct 20257:00 amRNS2025 Q3 Trading Update
13th Oct 20257:00 amRNSPPHC Files for Proposed U.S. IPO, Nasdaq Listing
2nd Oct 20257:00 amRNSCompletion of Share Consolidation & TVR
30th Sep 20257:30 amRNSDirectorate Changes
30th Sep 20257:30 amRNSReverse Stock Split Ratio
29th Sep 20255:21 pmRNSResult of Special Meeting of Shareholders
10th Sep 20257:00 amRNSNotice of Special Meeting of Shareholders
10th Sep 20257:00 amRNSInterim Results
5th Sep 20257:00 amRNSNotice of interim results & presentation via IMC
1st Aug 20257:01 amRNSUpdate re Liquidity & Capital Markets Profile
1st Aug 20257:00 amRNSCompletion of Acquisition, Issue of Shares and TVR
31st Jul 20258:35 amRNSNotification of Major Holdings
23rd Jul 20257:00 amRNSVesting of RSUs,Issue of Shares,PDMR Dealing & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.